Literature DB >> 1142705

[Biological activity of bacterial peptidoglycan (mucopeptide) (author's transl)].

B Heymer.   

Abstract

A brief survey on the ultrastructure, the chemical composition and the immunological properties of bacterial cell wall peptidoglycan (mucopeptide) is presented. This paper deals with the various recently discovered biological activities of peptidoglycan. These could be divided into three different groups, namely: 1. Endotoxin-like properties: pyrogenicity, induction of the local Shwartzman reaction, increase in non-specific resistance to bacterial infection, release of 5-hydroxytryptamine from rabbit platelets, complement activation,gelation of amebocyte lysate. 2. Inflammatory reactions of skin and internal organs, aggressin activity (virulence factor), inhibition of phagocytosis of bacteria by granulocytes and macrophages, inhibition of growth of cell cultures, cytotoxity to granulocytes and macrophages. 3. Potentiation of humoral and cellular immune responses (adjuvant), enhancement of tumor defense in experimental animals. The potential mechanisms of action of peptidoglycan are discussed and attention is focused on the implications of the various peptidoglycan activities for medicine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1142705     DOI: 10.1007/bf01482709

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  79 in total

Review 1.  Mechanisms of cell and tissue injury induced by group A streptococci: relation to poststreptococcal sequelae.

Authors:  I Ginsburg
Journal:  J Infect Dis       Date:  1972-10       Impact factor: 5.226

2.  The immunochemistry of peptidoglycan. Antibodies against a synthetic immunogen cross-reacting with peptidoglycan.

Authors:  K H Schleifer; P H Seidl
Journal:  Eur J Biochem       Date:  1974-04-16

3.  Pyrogenic activity of bacterial mucopeptides.

Authors:  J Rotta; K H Schleifer
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1974

4.  [Lymphocyte reaction to streptococcal antigens in patients with normal and elevated antistreptolysin titer].

Authors:  C P Sodomann; B Heymer; K Havemann; M Schmidt; B Schumacher; O Haferkamp
Journal:  Res Exp Med (Berl)       Date:  1973-03-14

5.  Toxicity of streptococcal mucopeptides in vivo and in vitro.

Authors:  B Heymer; B Bültmann; O Haferkamp
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

6.  Antimucopeptide antibodies and their specificity.

Authors:  M Rolicka; J T Park
Journal:  J Immunol       Date:  1969-08       Impact factor: 5.422

7.  Migration inhibition of rat peritoneal cells induced by streptococcal mucopeptides. Characteristics of the reaction and properties of the mucopeptide preparations.

Authors:  B Heymer; B Bültmann; W Schachenmayr; R Spanel; O Haferkamp; W C Schmidt
Journal:  J Immunol       Date:  1973-12       Impact factor: 5.422

8.  The immunochemistry of peptidoglycan. Separation and characterization of antibodies to the glycan and to the peptide subunit.

Authors:  K H Schleifer; R M Krause
Journal:  Eur J Biochem       Date:  1971-04-30

9.  Studies on cell walls of group A Streptococcus pyogenes, type 12. 3. Induction of cardiac lesions in mice by a higher molecular weight fraction from a digest of cell walls with the L-11 enzyme.

Authors:  T Narita; S Hamada; S Kotani; K Hasegawa; T Ishida
Journal:  Biken J       Date:  1971-09

10.  Cell Wall Component Which Affects the Ability of Serum to Promote Phagocytosis and Killing of Staphylococcus aureus.

Authors:  M Shayegani; K Hisatsune; S Mudd
Journal:  Infect Immun       Date:  1970-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.